I'm not writing biotech's obituary today. There's no way to predict exactly how far these stocks will retreat. But they are slowing down--and it looks like investors might be jumping off the bandwagon.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
Facebook has faced tech problems abound, key figures leaving and most recently the endless parade of negative media coverage. Taking everything into account, is it time to throw in the towel on this stock?
Today Greg is going to talk you out any hare-brained scheme you might have picked up on TV to go bargain hunting in biotech. But he will also going to show you where you can find some safe and steady gains in this market. Greg Guenthner shows you how to get your trading dollars working for you again…
Even with the market teetering near its lows, some compelling charts were beginning to emerge. In fact, one of our top candidates for market leadership was just beginning to show its potential. Greg Guenthner reports…
Are we witnessing the beginning of an epic small-cap comeback? Small stocks have taken the express elevator from the basement to penthouse. The sudden shift began Wednesday… Greg Guenthner reports…
Politics suck. But this election season, you’re getting paid. The Republicans have won back the Senate. And they’re about to hand you a winning trade on a silver platter— with a bit of soot around the edges. Yup, we’re going in on coal. And we’re probably the only ones with the cojones to do it. That’s alright, we don’t like crowds anyway. SO why should you buy these sooty, black rocks? Greg Guenthner explains…
Bitcoin went parabolic yesterday, quickly shedding $2000 in one night. But I don’t see the financial media turning on bitcoin just yet. This run might have some more rocket fuel left in the tank after blowing off some steam…